Global University Venturing

Ohio State University spun out a total of 13 companies in the last fiscal year and now has a portfolio with a record 98 active businesses.

Oklahoma State University has struck a partnership with Innosphere Ventures to support the commercialisation of its research.

The immuno-oncology company, based on University of Turin research, has completed a $21m series B round led by Claris Ventures.

Max Planck spinout Quench Bio will wind down after its target proved undruggable and will return capital to investors, which include AbbVie Ventures.

Hyundai, Kia and GV are contributing to a $350 PIPE in support of a reverse merger that will value the Maryland and Duke-linked company at $2bn.

Vorwerk Ventures and Blue Horizon Ventures have co-led a series A round for the ETH Zurich spinout selling plant-based meat products.

University of Pennyslvania and Caltech are in line for exits when Stanford’s online education spinout lists on the New York Stock Exchange.

Tsinghua Holdings has helped the venture fund, managed by DeePhi founder Yao Song, reach a $30.9m close.

Immuno-oncology therapy developer Lava Therapeutics has filed for a $100m IPO, having been set up in 2016 to exploit Amsterdam University Medical Centers research.

Versant Ventures, which incubated the cell-based immunotherapy developer based on Harvard and Stanford research, has backed a $160m round.